Member Exclusive

Pfizer and Concerto HealthAI partner to develop cancer therapies

Concerto HealthAI (MA, USA) has entered into collaboration with Pfizer (NY, USA), to make use of real-world data and provide actionable patient insights for Pfizer’s investigational therapies and commercialized therapeutics used to treat solid tumors and hematologic malignancies.

May 02, 2019
0
0

Please sign in or register for FREE

No comments yet.